Injectable Scaffolds for In Vivo Programmed Macrophages Manufacture and Postoperative Cancer Immunotherapy

[1]  T. Hyeon,et al.  Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy , 2021, Advanced materials.

[2]  Quanyin Hu,et al.  Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets , 2021, Nature Biomedical Engineering.

[3]  Yang Yang,et al.  Cell relay-delivery improves targeting and therapeutic efficacy in tumors , 2020, Bioactive materials.

[4]  Hai-bing Xiao,et al.  Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis , 2020, Bioactive materials.

[5]  D. Agrawal,et al.  Biomaterials-driven Sterile Inflammation. , 2020, Tissue engineering. Part B, Reviews.

[6]  Jingjing Ding,et al.  Viral Protein‐Pseudotyped and siRNA‐Electroporated Extracellular Vesicles for Cancer Immunotherapy , 2020, Advanced Functional Materials.

[7]  L. Deng,et al.  Microenvironment-responsive immunoregulatory electrospun fibers for promoting nerve function recovery , 2020, Nature Communications.

[8]  Jiabing Fan,et al.  Generation of Small RNA-Modulated Exosome Mimetics for Bone Regeneration. , 2020, ACS nano.

[9]  I. Kwon,et al.  Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity , 2020, Science Advances.

[10]  Haiyan Li,et al.  Modulation of macrophages by bioactive glass/sodium alginate hydrogel is crucial in skin regeneration enhancement. , 2020, Biomaterials.

[11]  Xiaomin Wang,et al.  Mimovirus Vesicle‐Based Biological Orthogonal Reaction for Cancer Diagnosis , 2020, Small Methods.

[12]  Hongmei Liu,et al.  Real‐Time Imaging Tracking of Engineered Macrophages as Ultrasound‐Triggered Cell Bombs for Cancer Treatment , 2020, Advanced Functional Materials.

[13]  Shengmin Zhang,et al.  Exosome-mimetics as an engineered gene-activated matrix induces in-situ vascularized osteogenesis. , 2020, Biomaterials.

[14]  Hai‐Yan Xie,et al.  Responsive exosome nano-bioconjugates for synergistic cancer therapy. , 2019, Angewandte Chemie.

[15]  Weidong Chen,et al.  Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation , 2019, Theranostics.

[16]  J. Elisseeff,et al.  A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy , 2019, Science Translational Medicine.

[17]  Quanyin Hu,et al.  In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment , 2018, Nature Nanotechnology.

[18]  M. Chapman,et al.  Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug Delivery , 2018, Advanced materials.

[19]  Yeon Woong Choo,et al.  M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. , 2018, ACS nano.

[20]  Weian Zhao,et al.  Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment. , 2018, ACS applied materials & interfaces.

[21]  Soong Ho Um,et al.  Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor‐Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy , 2018, Advanced materials.

[22]  R. Weinberg,et al.  The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy , 2018, Science Translational Medicine.

[23]  Zhuang Liu,et al.  In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy , 2018, Science Translational Medicine.

[24]  Lucas R. Smith,et al.  SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors , 2017, Current Biology.

[25]  Xin Fu,et al.  Structurally and Functionally Optimized Silk‐Fibroin–Gelatin Scaffold Using 3D Printing to Repair Cartilage Injury In Vitro and In Vivo , 2017, Advanced materials.

[26]  Yoosoo Yang,et al.  Virus‐Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes , 2017, Advanced materials.

[27]  H. Matlung,et al.  The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer , 2017, Immunological reviews.

[28]  Zhen Gu,et al.  In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy , 2017, Nature Biomedical Engineering.

[29]  Zhen Gu,et al.  Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody , 2016, Advanced materials.

[30]  Youqing Shen,et al.  Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy. , 2016, Small.

[31]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[32]  Stephen F. Badylak,et al.  A scaffold immune microenvironment , 2016, Science.

[33]  Y. Gho,et al.  In Vivo Differentiation of Therapeutic Insulin-Producing Cells from Bone Marrow Cells via Extracellular Vesicle-Mimetic Nanovesicles. , 2015, ACS nano.

[34]  S. Mitragotri,et al.  Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Lynda Wyld,et al.  The evolution of cancer surgery and future perspectives , 2015, Nature Reviews Clinical Oncology.

[36]  S. B. Stephan,et al.  Biopolymer implants enhance the efficacy of adoptive T cell therapy , 2014, Nature Biotechnology.

[37]  Kerry A. Daly,et al.  Macrophage polarization in response to ECM coated polypropylene mesh. , 2014, Biomaterials.

[38]  Claudiu T. Supuran,et al.  Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.

[39]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[40]  Samir Mitragotri,et al.  Cell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks , 2011, Advanced materials.

[41]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[42]  G. Giammona,et al.  Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. , 2010, Nanomedicine.

[43]  T. Brennan,et al.  Changes in Tissue pH and Temperature after Incision Indicate Acidosis May Contribute to Postoperative Pain , 2004, Anesthesiology.

[44]  Michael T. Lotze,et al.  Inflammation and necrosis promote tumour growth , 2004, Nature Reviews Immunology.

[45]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.